Related Experiment Video
Updated: Jul 8, 2026
08:49
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
An improved relaxed complex scheme for receptor flexibility in computer-aided drug design
Rommie E Amaro1, Riccardo Baron, J Andrew McCammon
1Department of Chemistry and Biochemistry, University of California at San Diego, La Jolla, CA, 92093-0365, USA. ramaro@mccammon.ucsd.edu
Journal of Computer-Aided Molecular Design
|January 16, 2008
Summary
The relaxed complex scheme (RCS) improves molecular recognition by accounting for receptor and ligand flexibility. This computational method enhances drug design by integrating docking with molecular dynamics simulations.
Area of Science:
- Computational chemistry
- Molecular modeling
- Biophysics
Background:
- Molecular recognition is complex due to dynamic interactions between associating molecules.
- Incorporating receptor flexibility is a significant challenge in computational drug design.
- Ligand flexibility is generally well-handled in current computational approaches.
Purpose of the Study:
- To review the relaxed complex scheme (RCS) methodology.
- To discuss advancements and improvements to the RCS for enhanced molecular recognition studies.
- To explore the application of RCS in ligand binding to specific biological targets.
Main Methods:
- The relaxed complex scheme (RCS) integrates docking algorithms with molecular dynamics (MD) simulations.
- RCS explicitly considers the flexibility of both receptors and docked ligands.
- Improvements include extensions to virtual screening and receptor ensemble optimization.
Main Results:
- RCS offers a promising approach for modeling dynamic molecular interactions.
- Enhanced RCS methods improve the characterization of binding effects and computational efficiency.
- The study discusses the impact of receptor ensemble selection and solvent effects on RCS predictions.
Conclusions:
- The relaxed complex scheme (RCS) provides a robust framework for studying molecular recognition with receptor flexibility.
- Ongoing methodological improvements are expected to further enhance the predictive power of RCS.
- Accurate treatment of solvent contributions remains an area for future development.
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
01:25Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
01:30Quantitative Aspects of Drug-Receptor Interaction
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
01:58Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
01:58Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...